CA3044344C - Utilisations diagnostiques de produits radiopharmaceutiques a courte duree de vie - Google Patents

Utilisations diagnostiques de produits radiopharmaceutiques a courte duree de vie

Info

Publication number
CA3044344C
CA3044344C CA3044344A CA3044344A CA3044344C CA 3044344 C CA3044344 C CA 3044344C CA 3044344 A CA3044344 A CA 3044344A CA 3044344 A CA3044344 A CA 3044344A CA 3044344 C CA3044344 C CA 3044344C
Authority
CA
Canada
Prior art keywords
bolus
radioactivity
radioactive
delivered
recipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3044344A
Other languages
English (en)
Other versions
CA3044344A1 (fr
Inventor
Martin Stenfeldt
Rune Wiik Kristensen
Peter Larsen
Original Assignee
Medtrace Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP16205724.4A external-priority patent/EP3338808B1/fr
Application filed by Medtrace Pharma AS filed Critical Medtrace Pharma AS
Publication of CA3044344A1 publication Critical patent/CA3044344A1/fr
Application granted granted Critical
Publication of CA3044344C publication Critical patent/CA3044344C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne l'utilisation de produits radiopharmaceutiques ayant une demi-vie radioactive inférieure à 21 minutes, telle que l'eau marquée à l'oxygène-15 (H2 15O) dans l'imagerie du flux sanguin à l'aide d'une technologie de balayage par TEP (Tomographie par Emission de Positons). L'invention concerne également l'utilisation d'un système de préparation et d'injection de bolus de tels produits
CA3044344A 2016-12-21 2017-12-21 Utilisations diagnostiques de produits radiopharmaceutiques a courte duree de vie Active CA3044344C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16205724.4 2016-12-21
EP16205724.4A EP3338808B1 (fr) 2016-12-21 2016-12-21 Utilisations diagnostiques de radiopharmaceutiques à courte durée de vie
PCT/EP2017/084128 WO2018115299A1 (fr) 2016-12-21 2017-12-21 Utilisations diagnostiques de produits radiopharmaceutiques à courte durée de vie

Publications (2)

Publication Number Publication Date
CA3044344A1 CA3044344A1 (fr) 2018-06-28
CA3044344C true CA3044344C (fr) 2025-12-16

Family

ID=

Similar Documents

Publication Publication Date Title
JP6942705B2 (ja) 放射線療法のための方法、装置、およびシステム
Abbott et al. Combining external beam radiation and radionuclide therapies: rationale, radiobiology, results and roadblocks
Cawthorne et al. Biodistribution, pharmacokinetics and metabolism of interleukin‐1 receptor antagonist (IL‐1RA) using [18F]‐IL1RA and PET imaging in rats
Gandhi et al. Theranostics in nuclear medicine: the era of precision oncology
Gallivanone et al. Targeted radionuclide therapy: frontiers in theranostics
CA3239322A1 (fr) Methodes de traitement radiopharmaceutique et utilisation
Lam et al. Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of 111In-BzDTPA-pertuzumab
Stahl et al. PET/CT molecular imaging in abdominal oncology
Müller et al. Targeted radiotherapeutics from'bench-to-bedside'
Song et al. Imaging of integrin αvβ3 expression in lung cancers and brain tumors using single-photon emission computed tomography with a novel radiotracer 99mTc-IDA-D-[c (RGDfK)] 2
Vernekar et al. Radiopharmaceuticals: a new vista for diagnosis and treatment of thyroid cancer
AU2017382946B2 (en) Diagnostic usages of short-lived radiopharmaceuticals
JP7030287B2 (ja) 短寿命放射性医薬品に対する輸液システム
Petrova et al. Estimation of absorbed doses in patients’ organs from the released radionuclide-label during radionuclide therapy with 225Ac
CA3044341C (fr) Systeme de perfusion pour produits radiopharmaceutiques a courte duree de vie
Barai et al. Evaluation of 99mTc‐L‐methionine brain SPECT for detection of recurrent brain tumor: a pilot study with radiological and pathological correlation
김수빈 Preclinical Internal Radiation Dosimetry Studies for Precision Radionuclide Therapy
Hannestad The application of PET imaging in psychoneuroimmunology research
Paphiti Dosimetry and Dose Calculation: Its Necessity in Radiopeptide Therapy
Waarde Introduction on pet: Description of basics and principles
Sivaprasad Application of radioisotope in Healthcare–An Overview
BR112018004403B1 (pt) Método, aparelho e sistema para radioterapia